Cardinal Health (NYSE:CAH) is scheduled to post its quarterly earnings results before the market opens on Thursday, November 8th. Analysts expect Cardinal Health to post earnings of $1.07 per share for the quarter.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Monday, August 6th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.08. The company had revenue of $35.35 billion for the quarter, compared to analysts’ expectations of $34.38 billion. Cardinal Health had a net margin of 0.19% and a return on equity of 22.59%. Cardinal Health’s revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.31 EPS. On average, analysts expect Cardinal Health to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
NYSE:CAH opened at $50.60 on Thursday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 0.53 and a current ratio of 1.07. Cardinal Health has a fifty-two week low of $48.14 and a fifty-two week high of $75.75. The firm has a market cap of $14.97 billion, a PE ratio of 10.12, a P/E/G ratio of 1.59 and a beta of 1.02.
CAH has been the topic of a number of research reports. Argus lowered their price objective on shares of Cardinal Health from $85.00 to $75.00 and set a “buy” rating on the stock in a research note on Monday, July 16th. Royal Bank of Canada reissued a “hold” rating and issued a $56.00 price objective on shares of Cardinal Health in a research note on Tuesday, August 7th. Robert W. Baird reissued a “hold” rating and issued a $51.00 price objective on shares of Cardinal Health in a research note on Friday, July 20th. Mizuho reissued a “hold” rating and issued a $53.00 price objective on shares of Cardinal Health in a research note on Sunday, August 12th. Finally, Zacks Investment Research lowered shares of Cardinal Health from a “hold” rating to a “sell” rating in a report on Tuesday, October 9th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company. Cardinal Health currently has a consensus rating of “Hold” and an average price target of $61.33.
In other news, CEO Jon L. Giacomin sold 2,890 shares of the stock in a transaction dated Monday, August 20th. The shares were sold at an average price of $51.95, for a total transaction of $150,135.50. Following the transaction, the chief executive officer now directly owns 72,652 shares in the company, valued at approximately $3,774,271.40. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.10% of the company’s stock.
About Cardinal Health
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Read More: Ex-Dividend
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.